Cite
HARVARD Citation
Curtis, J. et al. (n.d.). FRI0081 WITHDRAWAL OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN THE SARILUMAB OPEN-LABEL EXTEND STUDY: EFFICACY AND SAFETY ANALYSIS. Annals of the rheumatic diseases. pp. 702-703. [Online].